Dar es Salaam. The government has earmarked special investment zones for health product manufacturing industries and allocated more than Sh25 billion (over $10 million) as part of a broader strategy to strengthen investment and domestic production of medicines, vaccines and medical devices, with the aim of positioning Tanzania among leading producers of health commodities.
The announcement was made by the minister for Health, Mr Mohamed Mchengerwa, while addressing local and foreign investors interested in establishing health product manufacturing industries, during a meeting held in Dar es Salaam on January 19, 2026.
Mr Mchengerwa said the government was firmly committed to expanding local production of health products, adding that designated areas in Mloganzila and Kibaha had been officially set aside to host investors in the sector.
“These areas will be supported with quality infrastructure to bring investors together, ensure effective oversight, and promote research and development of health products. This will help to reduce production costs and accelerate manufacturing that meets international standards,” he said.
In support of pharmaceutical industrial investment, the government has also announced the provision of $10 million to establish a Shared Pharmaceutical Laboratory Facility that will serve all designated zones.
According to the minister, the facility will offer quality testing services, bio-equivalence studies and regulatory support, a move expected to reduce barriers for investors, shorten time to market and enhance compliance with World Health Organisation prequalification and Good Manufacturing Practice standards.
